| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |